Post date
31/03/2021
March 31, 2021 - Louvain-la-Neuve, Belgium: Tessares - a technology company specializing in Hybrid Access software - has just concluded a new round of funding to fast forward an innovative software
Post date
22/03/2021
LEUVEN, Belgium, March 22nd, 2021 — ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce
Post date
16/03/2021
Vaccines alone are not enough to fight Covid-19. Experts pinpointed during several occasions on the importance of having antibody-based treatments available in combination with vaccines.
This is
Post date
04/03/2021
Authorization to start clinical trial in the US granted for rare paediatric bone disease
Mont-Saint-Guibert, Mar 4, 2021 (GlobeNewswire) – Novadip Biosciences (“Novadip”), a clinical stage company
Post date
27/01/2021
Belgium – 27th January 2021 – Syndesi Therapeutics SA, a clinical stage biotechnology company developing novel modulators of the synaptic vesicle protein SV2A for the treatment of cognitive impairment
Post date
20/11/2020
New funding confirms Aphea.Bio’s frontrunner position in sustainable and innovative agriculture
GENT, NOVEMBER 20 - Aphea.Bio, a Belgium-based agtech startup, announced today that it secured a €14
Post date
24/11/2020
Tessares, a young company from Louvain-la-Neuve, has won an ultra-selective European subsidy of 1.2 million euros!
In Europe, more than 40% of homes in rural areas do not have a quality internet
Post date
21/10/2020
ViroVet : Animal health company focused on combatting viral infections in livestock
LEUVEN, Belgium, October 21th, 2020 — ViroVet NV, a leading Belgian biopharmaceutical company active in the
Post date
28/09/2020
Belgium – 28th September 2020 – Syndesi Therapeutics SA, a clinical stage biotechnology company developing novel modulators of the synaptic vesicle protein SV2A for the treatment of cognitive
Post date
05/10/2020
Novadip Biosciences, spin-off of UCLouvain and Cliniques universitaires Saint-Luc (UCLouvain) have achieved a world first in bone reconstruction. Very promising results for the treatment of rare
Post date
10/09/2020
Even when cured, people with Covid-19 have significant sequelae: neurological or cardiovascular disorders, fatigue, loss of respiratory efficiency…
Ath, September 10, 2020 - Botalys has developed a
Post date
02/09/2020
Promethera® Biosciences SA, a global innovator in cell-based medicines and liver diseases, based in Wallonia, Belgium, today announced that John Tchelingerian, PhD, has resigned from his position as